Royal Philips division Philips Respironics is set to exhibit its portfolio of connected sleep and respiratory solutions at the European Respiratory Society (ERS) International Congress 2016 to be held in London, UK.
The portfolio of solutions includes the Dream Family therapy system, which will see the addition of BiPAP autoSV and BiPAP AVAPS therapy devices.
Philips sleep business leader Mark D’Angelo said: “Philips Respironics has a long history of creating innovative technologies that are clinically proven to improve adherence and the overall patient experience.
“Continuing to build on the connectivity and usability of our solutions is an important way for us to better address the needs of patients by offering consistent support throughout their therapy, helping them live better lives.”
The Dream Family is an integrated therapy solution designed to facilitate a comfortable and effective sleep therapy for patients while keeping them connected with their care teams for optimal therapy management.
It consists of the DreamStation PAP device, DreamWear mask, and DreamMapper patient engagement application.
Philips is planning to add BiPAP autoSV and BiPAP AVAPS DreamStation devices in Europe to be used for patients suffering from complex sleep apnea, central sleep apnea, mixed apnea and / or periodic breathing, as well as patients with chronic respiratory insufficiencies.
EncoreAnywhere is developed as a patient compliance management system which offers physicians insight and the tools essential to improve the overall patient care.
The web-based platform is also designed to offer physicians and care teams a real-time remote access to important patient data with a view to allow adherence to therapy and efficient patient management.
